BECTON, DICKINSON AND COMPANY Deferred Income Tax Expense (Benefit)
BECTON, DICKINSON AND COMPANY (BDX) reported Deferred Income Tax Expense (Benefit) of -$474.00 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2025-11-25
- BECTON, DICKINSON AND COMPANY deferred income tax expense (benefit) for the quarter ending 2010-09-30 was -$23.05M, a 117.16% decline year-over-year.
- BECTON, DICKINSON AND COMPANY deferred income tax expense (benefit) for the quarter ending 2010-06-30 was -$7.04M.
- BECTON, DICKINSON AND COMPANY deferred income tax expense (benefit) for the quarter ending 2010-03-31 was $12.42M.
- BECTON, DICKINSON AND COMPANY deferred income tax expense (benefit) for the quarter ending 2009-12-31 was $1.71M, a 81.61% decline year-over-year.
- BECTON, DICKINSON AND COMPANY deferred income tax expense (benefit) for fiscal 2025 was -$474.00M.
- BECTON, DICKINSON AND COMPANY deferred income tax expense (benefit) for fiscal 2024 was -$211.00M.
- BECTON, DICKINSON AND COMPANY deferred income tax expense (benefit) for fiscal 2023 was -$622.00M.
- BECTON, DICKINSON AND COMPANY deferred income tax expense (benefit) for fiscal 2022 was -$129.00M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-09-30 | -$474.00M 10-K · filed 2025-11-25 | ||||
| 2024-09-30 | -$211.00M 10-K · filed 2025-11-25 | ||||
| 2023-09-30 | -$622.00M 10-K · filed 2025-11-25 | ||||
| 2022-09-30 | -$129.00M 10-K · filed 2024-11-27 | ||||
| 2021-09-30 | -$280.00M 10-K · filed 2023-11-21 | -$288.00M 10-K · filed 2021-11-24 | |||
| 2020-09-30 | -$285.00M 10-K · filed 2022-11-22 | -$286.00M 10-K · filed 2020-11-25 | |||
| 2020-03-31 | -$136.00M 10-Q · filed 2020-05-07 | ||||
| 2019-09-30 | -$633.00M 10-K · filed 2021-11-24 | ||||
| 2019-03-31 | -$109.00M 10-Q · filed 2020-05-07 | ||||
| 2018-09-30 | -$262.00M 10-K · filed 2020-11-25 | ||||
| 2017-09-30 | -$74.00M 10-K · filed 2019-11-27 | ||||
| 2016-09-30 | -$519.00M 10-K · filed 2018-11-21 | ||||
| 2015-09-30 | -$274.00M 10-K · filed 2017-11-22 | ||||
| 2014-09-30 | -$94.00M 10-K · filed 2016-11-23 | ||||
| 2013-09-30 | -$116.00M 10-K · filed 2015-11-25 | -$149.00M 10-K · filed 2013-11-27 | |||
| 2012-09-30 | -$52.00M 8-K · filed 2015-03-13 | -$52.19M 10-K · filed 2012-11-21 | |||
| 2011-09-30 | $17.00M 10-K · filed 2013-11-27 | $17.63M 10-K · filed 2011-11-23 | |||
| 2010-09-30 | -$23.05M derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-21 | -$30.09M derived: sum of 2 quarters · filed 2012-11-21 | -$17.67M derived: sum of 3 quarters · filed 2012-11-21 | -$15.96M 10-K · filed 2012-11-21 | -$16.07M 10-K · filed 2010-11-24 |
| 2010-06-30 | -$7.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-08-04 | $5.38M derived: sum of 2 quarters · filed 2010-08-04 | $7.09M 10-Q · filed 2010-08-04 | $141.37M derived: sum of 4 quarters · filed 2011-11-23 | |
| 2010-03-31 | $12.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-05-06 | $14.13M 10-Q · filed 2010-05-06 | $148.41M derived: sum of 3 quarters · filed 2011-11-23 | $120.41M derived: sum of 4 quarters · filed 2011-11-23 | |
| 2009-12-31 | $1.71M 10-Q · filed 2010-02-08 | $136.00M derived: sum of 2 quarters · filed 2011-11-23 | $108.00M derived: sum of 3 quarters · filed 2011-11-23 | $105.08M derived: sum of 4 quarters · filed 2011-11-23 | |
| 2009-09-30 | $134.29M derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-23 | $106.29M derived: sum of 2 quarters · filed 2011-11-23 | $103.37M derived: sum of 3 quarters · filed 2011-11-23 | $112.66M 10-K · filed 2011-11-23 | $60.04M 10-K · filed 2009-11-25 |
| 2009-06-30 | -$28.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-08-04 | -$30.92M derived: sum of 2 quarters · filed 2010-08-04 | -$21.63M 10-Q · filed 2010-08-04 | -$17.59M derived: sum of 4 quarters · filed 2010-11-24 | |
| 2009-03-31 | -$2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-05-06 | $6.37M 10-Q · filed 2010-05-06 | $10.41M derived: sum of 3 quarters · filed 2010-11-24 | ||
| 2008-12-31 | $9.29M 10-Q · filed 2010-02-08 | $13.33M derived: sum of 2 quarters · filed 2010-11-24 | |||
| 2008-09-30 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2010-11-24 | -$6.73M 10-K · filed 2010-11-24 | $80.09M 10-K · filed 2009-11-25 | ||
| 2008-06-30 | -$10.77M 10-Q · filed 2009-08-10 | ||||
| 2007-09-30 | -$115.49M 10-K/A · filed 2010-01-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |